BillionToOne to Participate in the Piper Sandler 38th Annual Healthcare Conference
MENLO PARK, Calif., Nov. 18, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced that Company management will participate in the Piper Sandler 38 th Annual Healthcare Conference.